MedTrace Logo

Breath Analysis in Asthma

NCT02450461 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2017-08-11

No results posted yet for this study

Summary

The purpose of this study is to answer the question whether a disease-specific profile of breath in patients with asthma can be detected by an untargeted metabolomic study using exhaled breath analysis by mass spectrometry.

Conditions

  • Asthma
  • Exhaled Breath
  • Mass Spectrometry

Interventions

OTHER

no intervention

Sponsors & Collaborators

  • Swiss Federal Institute of Technology

    collaborator OTHER

  • University of Zurich

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-06-30
Completion
2017-08-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02450461 on ClinicalTrials.gov